Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Apr 28, 2022 2:19pm
92 Views
Post# 34639769

RE:Board Of Directors

RE:Board Of DirectorsWill be interesting to see percentage approvals for members this year vs. last year. My recollection is that there were two noticeably lower percentage votes last year and those numbers were around the 70-75% levels versus 90%+ for everyone else. If anyone is below those 75% numbers we can conclude it would have been a larger shareholder voting "no".  I was hoping for the sake of resource conservation until such time it's 100% clear there's a larger commercial opportunity staring them in the face that the Chairwomen would have shrunk the Board back down.  If nothing else, then lower the fees for this year and up the options. We saw with Europe that management is looking for anyway to lower costs in future years, so help him out. But you are completely right that it's an "insider" Board that could use at least one, if not two, outsiders who think differently, think only of shareholder returns, and bring market saavy along.

I was hoping Soleus would have put someone up to the Chairwomen for that role or roles as she couldn't say no to that. Don't expect much change unless a Board member retires him/her self after seeing low vote tallies.  Past experience shows they don't jump off the gravy train, but any self-respecting member should take a bunch of shareholders specifically voting no as about the only strong way a message can be sent inside the bubble. And they should listen to it and move on.

palinc2000 wrote: I think it is  high time to  remove/replace the Chairwoman...She is the one responsible for determining the number of Directors and the qualifications required...
Most board members sit only on THTX s Board and no other public company s Board..They are not what you would  call a Select Club,,On the contrary they are perceived  here as the Montreal Club... .....
THTX Directors are very handsomely paid .......Objectivity and independance are at the core of a well run BOD .......I may be wrong but my impression is that we have a weak Board and my votes  against reflect that...




<< Previous
Bullboard Posts
Next >>